Paclitaxel induced apoptosis in breast cancer cells requires cell cycle transit but not Cdc2 activity. [electronic resource]
Producer: 20070423Description: 235-49 p. digitalISSN:- 0344-5704
- Antineoplastic Agents, Phytogenic -- pharmacology
- Apoptosis -- drug effects
- Blotting, Western
- Breast Neoplasms -- metabolism
- CDC2 Protein Kinase -- genetics
- Cell Cycle -- drug effects
- Cell Line, Tumor
- Cell Nucleus -- drug effects
- Cell Survival -- drug effects
- DNA Fragmentation -- drug effects
- Estradiol -- analogs & derivatives
- Flow Cytometry
- Fulvestrant
- Humans
- Hydroxyurea -- pharmacology
- Inhibitor of Apoptosis Proteins
- JNK Mitogen-Activated Protein Kinases -- antagonists & inhibitors
- Microtubule-Associated Proteins -- metabolism
- Microtubules -- drug effects
- Neoplasm Proteins -- metabolism
- Paclitaxel -- pharmacology
- Purines -- pharmacology
- RNA, Small Interfering -- genetics
- Roscovitine
- Spindle Apparatus -- drug effects
- Survivin
- Thymidine -- pharmacology
- Transfection
- bcl-Associated Death Protein -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.